Skip to main content

Table 2 Participant baseline characteristics

From: Feasibility, acceptability and efficacy of a text message-enhanced clinical exercise rehabilitation intervention for increasing ‘whole-of-day’ activity in people living with and beyond cancer

  Standard clinic (n = 18) Text message-enhanced clinic (n = 18) Overall (n = 36)
Age (years) 61.3 ± 9.1 68.3 ± 9.1 64.8 ± 9.6
Body mass index (kg/m2) 26.1 ± 4.2 26.5 ± 3.9 26.3 ± 4.0
Gender (male) 11 (61%) 12 (67%) 23 (64%)
Primary cancer
 Colorectal 12 (67%) 13 (72%) 25 (69%)
 Prostate 5 (28%) 5 (28%) 10 (28%)
 Breast 1 (6%) 0 (0%) 1 (3%)
Number of medications
 None 4 (22%) 4 (22%) 8 (22%)
 1 3 (17%) 2 (11%) 5 (14%)
  ≥ 2 11 (61%) 12 (67%) 23 (64%)
Post-diagnosis (months) 54.5 (38.0, 72.0) 60.0 (47.0, 71.0) 57.5 (43.5, 71.5)
Post treatment (months) 38.5 (25.0, 66.0) 51.0 (10.0, 61.0) 46.0 (24.5, 61.0)
Activity (activPAL micro)a
 Wear time (h) 15.7 ± 0.7 15.9 ± 0.9 15.8 ± 0.8
 Sitting (h/16 h) 9.4 ± 2.1 9.5 ± 1.8 9.4 ± 1.9
 Prolonged sitting (h/16 h) 4.6 ± 2.2 4.7 ± 1.8 4.7 ± 2.0
 Standing (h/16 h) 4.3 ± 1.5 4.3 ± 1.3 4.3 ± 1.4
 Stepping (h/16 h) 2.4 ± 0.8 2.1 ± 0.7 2.3 ± 0.8
 Light stepping (min/16 h) 95.3 ± 26.3 98.2 ± 22.8 96.7 ± 24.3
 MVPA (min/16 h) 43.7 ± 28.8 31.1 ± 19.4 37.4 ± 25
  1. MVPA moderate-to-vigorous physical activity. Table presents n (%), mean ± standard deviation or median (25th, 75th percentile) as appropriate
  2. aAverage daily activity monitored on valid days (≥10 h wear, ≥500 strides, < 95% of time in any one activity), excluding non-wear and sleep